Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 7 records, 1 pages
Search For: Varicella Vaccine
Global Varicella Vaccine Supply, Demand and Key Producers, 2024-2030
20 Feb 2024
Pharma & Healthcare
The global Varicella Vaccine market size is expected to reach $ 7108.9 million by 2030, rising at a market growth of 7.5% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Varicella Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Varicella Vaccine market size was valued at USD 4294.8 million in 2023 and is forecast to a readjusted size of USD 7108.9 million by 2030 with a CAGR of 7.5% during review period.
USD3480.00
Add To Cart
Global Chickenpox (Varicella) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
06 Jan 2024
Pharma & Healthcare
Chickenpox (Varicella) Vaccine
According to our (Global Info Research) latest study, the global Chickenpox (Varicella) Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Live Attenuated Varicella Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
08 Jan 2024
Pharma & Healthcare
Live Attenuated Varicella Vaccine
According to our (Global Info Research) latest study, the global Live Attenuated Varicella Vaccine market size was valued at USD 4294.8 million in 2023 and is forecast to a readjusted size of USD 5806.5 million by 2030 with a CAGR of 4.4% during review period.
USD3480.00
Add To Cart
Global Varicella Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
USD3480.00
Add To Cart
Global Chickenpox (Varicella) Vaccine Supply, Demand and Key Producers, 2023-2029
01 Feb 2023
Pharma & Healthcare
Chickenpox (Varicella) Vaccine
This report studies the global Chickenpox (Varicella) Vaccine production, demand, key manufacturers, and key regions.
USD4480.00
Add To Cart
Global Live Attenuated Varicella Vaccine Supply, Demand and Key Producers, 2023-2029
19 Feb 2023
Pharma & Healthcare
Live Attenuated Varicella Vaccine
The global Live Attenuated Varicella Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Varicella Vaccine
Total: 7 records, 1 pages
The global Varicella Vaccine market size is expected to reach $ 7108.9 million by 2030, rising at a market growth of 7.5% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Varicella Vaccine market size was valued at USD 4294.8 million in 2023 and is forecast to a readjusted size of USD 7108.9 million by 2030 with a CAGR of 7.5% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Chickenpox (Varicella) Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Live Attenuated Varicella Vaccine market size was valued at USD 4294.8 million in 2023 and is forecast to a readjusted size of USD 5806.5 million by 2030 with a CAGR of 4.4% during review period.
USD3480.00
Add To Cart
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
USD3480.00
Add To Cart
This report studies the global Chickenpox (Varicella) Vaccine production, demand, key manufacturers, and key regions.
USD4480.00
Add To Cart
The global Live Attenuated Varicella Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>